Clinical Need
Addressing Unmet Challenges
____
Bilitech’s Regenerative Medicine Solutions break new ground into a previously unexploited £8bn market
![liver redux](http://bilitech.co.uk/home/wp-content/uploads/2021/06/liver-redux.png)
350,000 new cases per annum with bile duct diseases
![Scapel redux](http://bilitech.co.uk/home/wp-content/uploads/2021/06/Scapel-redux.png)
75,000 new cases per annum with disease affecting large ducts amenable to surgical replacement
![Syringe redux-1](http://bilitech.co.uk/home/wp-content/uploads/2021/06/Syringe-redux-1.png)
275,000 new cases per annum with diffuse disease affecting small ducts not amenable to surgery
![recycle redux](http://bilitech.co.uk/home/wp-content/uploads/2021/06/recycle-redux.png)
Minimal treatment options other than surgery or a liver transplantation
![Percent redux](http://bilitech.co.uk/home/wp-content/uploads/2021/06/Percent-redux.png)
Accounting for 30% of adult and 70% of paediatric liver transplantation